The publisher's Medical Devices sector report, “Drugs of Abuse Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update' provides comprehensive information about the Drugs of Abuse pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Drugs of Abuse Tests are used for the detection of illegal and/or prescribed substances in the patient samples including urine, blood, saliva, or sweat.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Drugs of Abuse Tests are used for the detection of illegal and/or prescribed substances in the patient samples including urine, blood, saliva, or sweat.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Drugs of Abuse under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Drugs of Abuse and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Drugs of Abuse under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Drugs of Abuse - Pipeline Products under Development by Companies
5 Drugs of Abuse Companies and Product Overview
6 Drugs of Abuse- Recent Developments
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Accelerate Diagnostics Inc
- Adaltis Srl
- Banyan Biomarkers Inc
- Behavioral Diagnostics Inc
- BioMark Technologies Inc
- Ceres Nanosciences Inc
- genedrive plc
- Horiba Ltd
- OpalGenix Inc
- Randox Laboratories Ltd
- Roche Diagnostics International Ltd
- SDI Biomed, Inc.
- SensoDXII LLC
- Siemens Healthcare Diagnostics Inc
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc
- University of California San Francisco
- ZORA Biosciences Oy
